GenomeDx Biosciences Investors

21 investors on Angel Roster list GenomeDx Biosciences in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Seed and the largest groups are based in the United States, the United Kingdom and China.

Investors are matched on the company name in their portfolio, so companies that share the name GenomeDx Biosciences can appear together.

Investors listed
21
With verified email
52%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 21 GenomeDx Biosciences investors

The most complete profiles first. Showing 21 of 21.

  • Andrew FergusonVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Verified email available

  • Michael HolgateVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Verified email available

  • Nina EssandohVerified

    Venture Capital, Founder, Investor · United States

    SeedHealth CareHospitalsE-commerceAccounting

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Verified email available

  • Adam WhiteheadVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Andy TseVerified

    Venture Capital · China

    Health CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Verified email available

  • Ben WessnerVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Brian EnglanderVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Brian McGregorVerified

    Venture Capital · United States

    Health CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Verified email available

  • Dylan HarmonVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Scott LiVerified

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Todd HolmesVerified

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Verified email available

  • Aidan Elliott

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedPre-SeedHealth CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Contact details available

  • James Benfield

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    SeedHealth CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Contact details available

  • Rob Ospalik

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Contact details available

  • Huaming Gu

    Venture Capital · China

    Health CareHospitalsAccountingPayments

    Portfolio: Arroweye Solutions, Wuhan Kindstar Diagnostics, Aura Futures, Strata Oncology and 56 more

    Contact details available

  • Justin Waney

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Luke Duster

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Nate Hukill

    Venture Capital, Private Equity Firm · Puerto Rico

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Sami Hawwa

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • Zain Shekhani

    Private Equity Firm · United States

    Health CareHospitalsWomen FoundedBiotechnology

    Portfolio: HNI Healthcare, Navidea Biopharmaceuticals, Astute Medical, T2 Biosystems and 37 more

    Contact details available

  • George Rehm

    Investor

    Portfolio: Tethys BioScience, GenomeDx Biosciences, BioPheresis

    Contact details available

Frequently asked questions

How many GenomeDx Biosciences investors are on Angel Roster?

Angel Roster lists 21 GenomeDx Biosciences investors. 11 of them (52%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (16), Venture Capital Firms (14) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do GenomeDx Biosciences investors invest in?

Among those that list a stage, the most common are Seed (6) and Pre-Seed (1).

Where are GenomeDx Biosciences investors based?

Most are based in the United States (13), the United Kingdom (4) and China (2).

Which companies have GenomeDx Biosciences investors backed?

The most-backed portfolio companies among them are Navidea Biopharmaceuticals (11), HNI Healthcare (11), Biodesix (11), Outset Medical (11) and AFT Pharmaceuticals (11).

How do I contact GenomeDx Biosciences investors?

Create a free Angel Roster account to search and filter all 21, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.